• Wildflower Brands is focused on being a global supplier of CBD products for wellness and health
• The company now distributes in over 600 locations in the United States alone, and it recently signed an agreement with a firm in Poland to enter the European Union marketplace
• The company’s online sales have increased by more than 300 percent since 2018 and are growing by 40 percent from month to month

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a cannabis company that develops cannabis-based brands and products for health and wellness. This company’s goal is concerned with the manufacturing, distribution, marketing and retail of CBD products, as well as research and development of new and innovative products so as to produce a global wellness brand. The demand for cannabis-based products is expected to increase in the coming years, with profits predicted to soar in the future; this is a trend that is already evident in North America and Europe. In fact, the CBD market is projected to reach about $22 billion by the year 2020. The market for cannabis-based products is expected to increase in the future as CBD becomes more popular and legislation changes, allowing further expansion into the marketplace and enabling more products to become available for retail.

Wildflower Brands has an impressive distribution system in the United States, with more than 20 retailers in New York City and more than 200 retailers in Washington State. Currently, the company distributes its products in over 600 locations across the United States. Part of the reason for this sizable distribution network is the company’s agreement with the well-known and nationwide Dillard’s department store chain, which positions Dillard’s as a distributor for certain Wildflower Brands products.

Wildflower Brands is a leading cannabis product supplier, showing record profits. The company had revenue of $1.8 million at the end of March 2019 and has shown increasing revenue and profits for the last nine consecutive quarters. Wildflower Brands has increased its online product sales by over 300 percent since early 2018. The online sales have grown by 40 percent from month to month.

Notably, Wildflower Brands has also reached an agreement with Free People to sell its CBD products online (http://ibn.fm/ZsB8V).

The company has grown to span various entities, including Wildflower Wellness, Kings Extract and Exclusive. These entities enabled the further expansion of Wildflower Brands products into new markets and increased the distribution capability of the company. Wildflower Brands has also formed a partnership with Retail Worx to further facilitate the retail of CBD products within New York City. Wildflower Brands has also opened up two locations in British Columbia, Canada (http://ibn.fm/Hnmqi). These locations fall under subsidiary City Cannabis Corp. Wildflower Brands Inc. expects to expand further into the Canadian marketplace in the near future, with increasing revenue and profits forecast.

Wildflower Brands is keen on expansion into the global marketplace with a view toward moving into the regions of the world where CBD products are not as legally restricted in terms of sales and distribution. An agreement has been signed to enter the European Union marketplace by way of Poland. The agreement with Polish firm Two Towers was signed in April 2019. Wildflower Brands Inc. has plans for further expansion and distribution into the Asian marketplace in the near future.

The company has expanded tremendously since first being founded in 2012 as a private company. It became a public company in 2014, and, since then, the company has increased in prominence and achieved rising profits. It is not surprising that Wildflower Brands is doing well, considering the steps the company takes in partnering with other businesses and the steps it takes to move into and invest in new distribution hubs and markets around the world.

William MacLean, CEO of the company, also attributes much of the success of Wildflower Brands to the team it has assembled, with individuals who have the know-how to successfully achieve licensing and establish the brand in locations that are most likely to be successful in the long term. As a result, the company has 14 licenses for cannabis in the state of California. These licenses include the cultivation of medical and recreational cannabis, as well as the manufacturing, distribution and retail of such products. Wildflower Brands is uniquely positioned to be one of the top brands for cannabis-based products in the future.

For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at  http://ibn.fm/WLDFF

• Pressure BioSciences was described as an integral part of women’s cancer research efforts during a presentation last month at the International Gynecologic Cancer Society conference in Brazil
• The company’s patented pressure cycling technology provided a key link in a trio of procedures for analyzing biopsied cells
• Gynecologic cancers are diagnosed in the United States at a rate of nearly 100,000 women per year, and the global gynecological cancer drug market is expected to generate revenues of more than $41.8 billion by 2026

A new, novel workflow for the analysis of proteins from cancer biopsy samples was recently disclosed at a major international gynecologic cancer meeting. This innovative workflow is expected to markedly enhance cancer diagnosis, prognosis and effective treatment therapies. The revelation of this new workflow has augmented the reputation of Pressure BioSciences Inc. (OTCQB: PBIO) amid the modern science rush to build better precision medicine for malignancies that claim hundreds of thousands of lives each year in the United States alone (http://ibn.fm/vawZS).

Human biology is complex, but scientific advances in the field of big data analysis have provided remarkably advanced tools for attempting repairs on the constellation of minuscule pieces of the human machine that may break down.

Efforts to develop an optimal means of analyzing proteins from cancer biopsy samples led one group of top gynecologic researchers to a new, innovative workflow that utilizes Pressure BioSciences’ patented pressure cycling technology (PCT) platform as the bridging mechanism in a process that begins with Leica Microsystems’ laser microdissection (LMD) platform and ends with comprehensive analysis on a ThermoFisher Scientific mass spectrometry (MS) instrument.

Pressure BioSciences’ PCT platform, as an integral part of the analytical trio, prepares the excised cells for micro-scale quantitative proteomics and phosphoproteomics – the large-scale study of proteins and their phosphorylation-based signaling networks – by provoking rapid and efficient high-quality cellular protein release and preparation from the biopsy samples. The entire sample preparation process is done in the company’s proprietary Barocycler 2320EXT system.

The researchers presented an explanation of their working process in searching for ways to combat gynecological cancers during a core session of the annual International Gynecologic Cancer Society (“IGCS”) conference last month in Rio de Janeiro, Brazil. Dr. Larry Maxwell, a gynecologic oncologist and the OB-GYN chairman at Northern Virginia’s Inova Fairfax Hospital, described the PCT-based Barocycler system technology provided by Pressure BioSciences as “an essential requirement for our novel workflow in meeting our goals” in his presentation to the IGCS.

“The conventional use of chemotherapy in ovarian cancer treatment is being rapidly replaced by biologic therapeutics that target the cancer (the ‘seed’) and also the micro-environment (the ‘soil’) in which it grows,” Maxwell stated in a news release (http://ibn.fm/fo6x7). “Being able to collect small tissue specimens and characterize them across multiple genomic and proteomic platforms will enable us to markedly enhance our ability to develop companion diagnostics and prognostics as well as identify targets for future therapeutic strategies.”

Protein chemist Dr. Thomas Conrads, the senior director of women’s health research at the Inova Women’s Hospital, added, “We believe that the insights we gain from applying this novel workflow will result in significant improvements in the clinical management of gynecologic cancer.”

Gynecologic cancers are diagnosed at a rate of nearly 100,000 women per year in the United States (http://ibn.fm/koVZR). Aurora Healthcare estimates that more than 30,000 of those patients die each year (http://ibn.fm/EezJZ). Publication The Pharma Letter, citing analysis by Persistence Market Research Report, states that the worldwide market for gynecological cancer drugs is expected to expand at a CAGR of 6.2 percent between 2018 and 2026, generating revenues of more than $41.8 billion (http://ibn.fm/aeE8t), with most of the costs led by the United States. The importance of effective therapies in terms of life-saving measures and product costs is apparent, and it serves as an indicator of PBIO technology’s potential attractiveness to other research labs.

Pressure BioSciences continues adding a number of significant achievements to underscore the reputation of its technology. Recently, the company announced an agreement with a world-renowned, multibillion-dollar biotherapeutics firm that will use PBIO’s proprietary BaroFold(TM) technology to improve the manufacture of a protein drug (http://ibn.fm/KaqJ1). Protein-based therapeutics are a growing part of the global health care industry, which is projected to reach nearly $249 billion in revenues by next year, according to Research and Markets analysis (http://ibn.fm/RIKAI).

For more information, visit the company’s website at www.PressureBioSciences.com

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

• The Pinnacle Combat Fight Group made its B2 Fighting Series fall season debut with nine amateur and three professional fights
• HRMMA Fight Group CEO and Founder Vanessa Higdon received an important award recognizing her contribution to MMA’s development; HRMMA is one of the key brands under the B2Digital umbrella
• As part of its growth strategy, B2Digital plans to continue developing and acquiring MMA and sports-related brands to ensure full vertical integration

B2Digital Inc. (OTC: BTDG), a full-service live events sports company, announced a couple of exciting new developments in late September and the beginning of October 2019. The company issued an update regarding its B2 Fighting Series fall season, which began with Colosseum Combat 50 in Kokomo, Indiana, on September 14. The season continued with the Pinnacle Combat Fight Group’s debut on September 28 (http://ibn.fm/84nSk).

The second event of the B2 Fighting Series, Pinnacle Combat Fight Group made its debut at McGrath Dubuque Harley Davidson in Dubuque, Iowa, with nine amateur and three professional fights and a professional flyweight headliner between Jeff Jepsen and Nathan Williams.

The B2 Fighting Series fall schedule, consisting of 10 live MMA fights in 10 different states, will continue with the HRMMA Fight Group event in Covington/Cincinnati, Ohio, on October 12.

The HRMMA event comes after the group’s founder and CEO, retired mixed martial arts fighter Vanessa Higdon, was honored with the 2019 Danny Davis Lifetime Achievement Award by the Kentucky Boxing and Wrestling Commission, according to a B2Digital press release (http://ibn.fm/IjzdP).

The award recognizes individuals who have outstanding accomplishments in Kentucky’s combat sports field. There have been multiple renowned previous winners, including Muhammad Ali (awarded posthumously).

Higdon initiated her MMA career in 2003, when she started working with other fight groups to promote the business aspect of live events. In 2006, Higdon became an MMA fighter who competed in several events until her retirement in 2008. In 2017, HRMMA became part of the B2Digital B2 Fighting Series.

Over the course of 11 years, Higdon executed 110 live MMA events. Her skills, experience and industry know-how position her as a crucial B2Digital executive team member. “Vanessa is one of the top CEOs in the MMA industry and it was a proud moment to watch her win this Lifetime Achievement Award. She does an excellent job operating HRMMA and developing MMA in her area. This is one of the most exciting parts of leading B2Digital – to work alongside and mentor Vanessa and the up-and-coming CEOs in the B2 Fighting Series,” B2Digital CEO and Chairman Greg P. Bell said in a news release.

B2Digital applies its extensive background in entertainment, television and video to the live sports events field. The company also capitalizes on its strong management team and hands-on experience to develop and acquire MMA and sports-related brands. Its ultimate goal is to build an integrated premier development league, initially focused on the billion-dollar MMA marketplace.

As a part of its growth strategy, B2Digital intends to continue developing and acquiring assets that fall in line with the company’s business model. Such acquisitions are expected to enable B2Digital to become a fully vertically integrated live event sports company.

For more information, visit the company’s website at www.B2DigitalOTC.com

NOTE TO INVESTORS: The latest news and updates relating to BTDG are available in the company’s newsroom at http://ibn.fm/BTDG

• ETST’s Hygee(TM) home testing kit for STIs helps women discreetly detect diseases
• The CDC estimates that there are 20 million new STI cases each year

As sexually transmitted infections (STIs) are reaching epidemic proportions worldwide, especially in remote regions with limited access to health care, men and women are searching for tools to take control of their sexual health. Earth Science Tech Inc. (OTCQB: ETST), a diverse biotech company focused on the nutraceutical and pharmaceutical fields, has developed the revolutionary Hygee(TM) home testing kit that allows women to screen for STIs like chlamydia and gonorrhea from the comfort of their own homes.

STI is an umbrella term encompassing 35 infectious organisms that are transmitted primarily through sexual activity (http://ibn.fm/6AFTz). The Centers for Disease Control and Prevention (CDC) estimates that there are approximately 20 million new STD infections each year. Furthermore, the CDC estimates that undiagnosed and untreated STDs cause infertility in some 24,000 women in the U.S. each year. This creates an unmet demand for a discreet in-home screening tool like Hygee, which looks like – and is worn like – a standard panty liner.

“The best way to fight STIs is prevention, and the only way for women to avoid the dangerous results of untreated STI, is early treatment,” ETST CEO and Chief Science Officer Dr. Michel Aubé stated in a news release (http://ibn.fm/qUHno). “This means that women need to know if they are infected. We believe that Hygee(TM) will be the best tool to provide that information.”

Currently, most cases of STIs remain undiagnosed and untreated, posing a danger to pregnant women and their unborn babies. Results may include infertility in women and blindness or stillborn death in infants (http://ibn.fm/sjvOC). Not only does ETST provide a private screening tool, it also provides access to treatment recommendations through its partner testing lab.

Through Hygee, ETST offers the utmost in privacy for women suspecting that they may have an STI, which could be a key factor in decreasing the number of infections that remain undiagnosed each year. While many women may fear the stigma of being diagnosed with an STI, Hygee addresses that problem. The kit is for home use and conducted anonymously. Results are transferred through the mail, and women can read their lab results in private. By enabling more women around the world to have access to an easy, private screening tool, it may be possible to stem the flood of STIs globally.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• SRAX presented at the 5th Annual B. Riley Consumer & Media Conference
• CEO and Founder Christopher Miglino discussed the company’s impressive growth and upcoming initiatives during a NetworkNewsWire interview
• BIGtoken offers consumers control of and compensation for data

Digital marketing and consumer data management technology company SRAX Inc. (NASDAQ: SRAX) showcased its presentation yesterday at the 5th Annual B. Riley Consumer & Media Conference at the Sofitel Hotel in New York City (http://ibn.fm/OlIGi). CEO and Founder Christopher Miglino also met with investors and participated in a fireside chat with analyst Mike Crawford during the premier event.

SRAX is expanding its revenue streams by monetizing its datasets through various platforms. SRAX CEO and Founder Christopher Miglino joined Stuart Smith from NetworkNewsWire on September 19, 2019, for an audio interview reviewing the company’s impressive growth pattern during the past year and discussing future plans (http://ibn.fm/VKK4x).

“Our goal is to build the most valuable opted-in data set in the world,” Miglino stated in the interview. “We’ll have more consumers that have opted in to let us sell access to their data than any other company, and that’s invaluable.”

Miglino further stated that, as consumers realize the value potential of data, they are retaining their information. Privacy concerns are high, with governments passing laws that control the amount of data that website publishers such as Facebook, Twitter and Snapchat can access. SRAX provides companies with a secured privacy solution through the BIGtoken platform. SRAX has also teamed up with several high-profile nonprofit associations so that BIGtoken can contribute their earnings.

Developed by SRAX, BIGtoken can be downloaded from both the App Store and Google Play. The platform boasts over 16 million BIGtoken registered users worldwide and provides consumers with a safe and transparent environment for optimization and monetization of their data (http://ibn.fm/p4vn5). In exchange for giving brands access to their data by answering surveys, checking into locations, referring friends and more, BIGtoken users are rewarded with points, which they can then redeem for cash or gift cards.

SRAX works across many industry verticals and uses its technology to identify target consumers for brands and companies in the CPG, automotive, investor relations, luxury and lifestyle industries. By integrating data using verified consumer participation, the company provides useful insights to its client brands to keep those brands ahead of the competitive curve.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• HTC Extraction Systems has developed a proprietary ethanol-based distillation system called the Delta Purification System®, which works with the company’s DeltaSolv™ technologies
• The company published unaudited interim condensed consolidated financial results in August that show three-fold revenue gains over the previous year’s reporting period based on its ethanol, solvent and glycol reclamation operations
• HTC Extraction Systems is completing facilities in Saskatchewan for an identity preserved production, hemp biomass tolling and cannabidiol full-spectrum oil distillation operation

The proprietary ethanol, solvent and glycol reclamation operations of HTC Extraction Systems (TSX.V: HTC) granted the Saskatchewan, Canada-based company a three-fold increase in revenue during the past year, according to unaudited interim condensed consolidated financial results published August 28 (http://ibn.fm/EzRWR).

The condensed report, covering HTC Extraction Systems and its subsidiaries for the interim six-month period ended June 30, states that the company’s carbon dioxide extraction business and material handling operations drove revenues from $560,260 in 2018 to $1.85 million this year.

During that same period, the company’s total assets increased from $34.07 million to $35.29 million as HTC Extraction Systems built its strategy for extracting cannabidiol full-spectrum oil (“CBD FSO”) from hemp biomass for distillation. The company and its subsidiaries believe that their patented Delta Purification® System offers the best available environmental reclamation technology for the clean energy extraction and biomass extraction industries. HTC has finalized a hemp biomass tolling agreement that will result in the company processing an expected five million kilograms of identity preserved production hemp biomass, and it is completing negotiations to establish an identity preserved production hemp biomass tolling contract, with a 60,000-acre, recognized Canadian farm leader and significant hemp biomass producer, to extract the CBD FSO. The company then plans to use the tolling fee payable under the tolling contracts, in sales and offtake agreements with its related entity, Purely Canada Foods.

HTC Extraction Systems anticipates that, upon implementation of its intellectual property through its extraction and purification system, the hemp byproducts will be available for singulation and sale to the cannabinoid pharmaceutical market.

The unaudited interim condensed consolidated financial report also states that the company’s current liabilities decreased from $4.60 million in 2018 to $3.19 million this year, while long-term liabilities increased from $7.67 million last year to $8.69 million this year.

An increase in amortization of $914,805 over the previous year reflects the completion of building projects in 2018. The company has completed to exterior lock-up and is finalizing the interior of a 19,000-square-foot extraction tolling facility compliant with GMP Euro specifications. In addition, it is constructing a 27,000-square-foot facility for the storage and processing of pre-extraction biomass, located on six acres of land in Port Lajord, Saskatchewan, about 17 miles southeast of Regina – the province’s capital city and a cultural and commercial center for the southern part of the province.

The facility will include the Delta Purification® systems, distillation and refining equipment, with laboratory quality control and testing operations, utilizing the company’s trademarked DeltaSolv technologies that are custom-designed, ethanol-based solvent mixtures and additives optimized for efficient reclamation.

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

• ChineseInvestors.com offers first-rate financial information and innovative CBD products
• CBD is poised to become one of China’s largest industries over the next decade
• CIIX is at the vanguard of what may become the world’s largest CBD market

Offering an array of investor education products and services, ChineseInvestors.com Inc. (OTCQB: CIIX) provides web-based, real-time financial information in Chinese language character sets. Not only is it a top financial information website for Chinese-speaking investors in the U.S. and China, CIIX is also becoming a major player in the emerging CBD (cannabidiol) market for CBD-based nutrition and health products in China. The company is focusing back on its original mission of providing financial information and services to the larger Chinese community in the U.S. and globally while exploring major CDB market opportunities. As the disposable income of the average Chinese consumer continues to grow, CIIX is making moves to penetrate the steadily growing Chinese CBD market.

Through wholly owned enterprise CBD Biotech Inc., CIIX is implementing its CBD initiatives. At present, CIIX is at the vanguard of what may become be the globe’s largest CBD market: China (www.CIIXInfo.com). The company recognizes the untapped CBD market for Chinese-speaking individuals, specifically in the health care sector, which is expected to grow by as much as 10 percent per year. Due to a higher spending power from consumers, China’s demand for medicinal products such as those made from hemp-based CBD has risen. Analysts foresee China’s CBD market reaching over $20 billion by 2022, and CIIX is uniquely positioned to meet this consumer demand. CIIX is hoping for a Nasdaq IPO of CBD Biotech late in FY2019 or early in 2020.

CIIX developed its unique niche by concentrating on the Chinese-speaking markets where it has historically generated success. This bodes well for its CBD strategy. The company has created a three-year development plan to take advantage of mainland China’s interest in CBD-infused health and wellness products. Realizing that CBD is anticipated to become one of China’s largest industries over the next 10 years with a potential market of close to two billion people, CIIX’s strategy aims to educate consumers about the benefits of CBD oil.

CIIX is no stranger to the CBD market, as it operated one of the first Chinese-language CBD stores online. It also opened its initial CBD pop-up kiosk in Glendale Galleria Mall in California. This past February, CIIX launched its rebranded CBD consumer product line and consolidated its retail ecommerce outlets into a single site, www.365CWC.com. CIIX now offers consumers opt Hemp, which includes products infused with industrial hemp derived CDB. It additionally offers opt2mist(TM), a spray vitamin product line featuring full spectrum hemp-derived CBD-infused formulas.

CBD Biotech has its own product lines specifically designed for the Chinese market internationally. These include CBD Biotech’s Live Oxygen Series and its Magic Hemp Series.

The numbers show support for CIIX’s CBD-driven direction. Hemp and CBD sales were a key driver in its recent robust quarterly performance. For the third quarter of FY2019, ended February 28, 2019, CIIX reported total revenue of $1.4 million. This represents an increase of 81 percent from the same quarter of FY2018. Hemp and CBD sales increased almost 600 percent in Q3, reaching $1.1 million. Recently, CBD Biotech was a featured exhibitor at the Vietnam Expo, where it introduced its hemp-infused skincare line and hemp wine, which is expected to add to future sales growth.

CIIX continues to focus on investor education products and services and compelling CDB opportunities. The company offers investors the potential for portfolio gain because of its focus on highly diversified revenue streams. With its emphasis on premier financial information as well as high quality hemp-based CBD products, CIIX continues its march toward greater growth and profits for all its stakeholders.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• GP Solutions is dedicating a series of its innovative and disruptive GrowPod agricultural solutions to the cannabis market through an agreement with rapper and cannabis advocate Snoop Dogg
• The company introduced its ‘Snoop’s Premium Nutrients Pods’ to popular acclaim at the recent CannaCon South convention in Oklahoma City
• Oklahoma is a significant target market, because it has one of the most business-friendly medical marijuana licensing initiatives in the country; GP Solutions expects to open a GrowPod showroom and sales office in Tulsa this month
• The Tulsa facility will also include a training and educational center to teach students about new advances in high-tech agriculture, playing on GrowPods’ advances in cultivating clean and healthy vegetables and herbs for a variety of markets
• GP Solutions also applied for uplisting to the OTCQX Best Market during the past month in an effort to add more value to stockholders’ portfolios

Agricultural technology innovator GP Solutions (OTC: GWPD) recently signed an agreement with rapper, media personality and business builder Snoop Dogg to dedicate some of the company’s innovative and automated micro-farms to a co-branding venture with the ganjapreneur, developing a series of its trademarked GrowPods to be configured as ‘Snoop’s Premium Nutrients Pods’.

The deal is part of a venture through which GP Solutions will become a distributor of Snoop’s Premium Nutrients, a premier product line developed in Holland for the cannabis market (http://ibn.fm/pzHE5). Snoop Dogg is a longtime advocate of legal cannabis, and customers who purchase one of his branded pods will receive a six-month supply of the premium nutrients as part of each package.

GP Solutions debuted the first Snoop’s Premium Nutrients Pods at the CannaCon South convention in Oklahoma City in late September. The company’s GrowPods are designed for easy operation, streamlining the start-up process to allow users of all levels of experience to begin farming and generating revenue as rapidly as possible.

“Our Snoop’s Premium Nutrients Pods were the hit of the show,” GP Solutions CEO George Natzic stated in a news release (http://ibn.fm/MsYHh). “Not only was the interest level incredibly high, but we are also in the process of closing multitudes of deals.”

It’s been a little over a year since Oklahoma voters approved one of the most business-friendly medical marijuana initiatives in the country, granting the state its status as the only market in the United States where more grower licenses have been issued than dispensaries and processors combined, according to Marijuana Business Daily (http://ibn.fm/KMd4z).

GP Solutions announced at the beginning of September that it will open a GrowPod showroom and sales office in Tulsa, Oklahoma, in a facility that will also feature a training and educational center to teach students about new advances in high-tech agriculture and to train customers on the operation of GrowPods (http://ibn.fm/m4KkM).

The company’s Oklahoma operation, scheduled to open to the public later this month, will place it at the heart of the exploding legal cannabis industry, but also in the heartland of one of the largest agriculture markets in the world. GrowPods have previously been used to cultivate clean and healthy vegetables and herbs for a variety of markets, including restaurants, grocery, organics, farm stands and traditional farming, allowing for growth of a new category of ‘Superfoods’ that are “better than organic.”

GrowPods’ advantages include an average of eight-times more yield than other forms of agriculture, indoor cultivation that provides year-round growth and consequently greater opportunity for generating revenue, portability that allows the pods to be set up virtually anywhere, high water and power resource efficiency, and easy scalability thanks to the stackable pod design.

The pods are also pesticide-free and protected from bacteria through the utilization of sealed environments.

“The Oklahoma Center has the potential to become a tremendous growth driver for the company,” Natzic stated.

Regarding the Snoop’s Premium Nutrients Pods, he added, “This is an enormous opportunity for our company that will heighten visibility in the cannabis market and give growers a complete solution for rapid and robust cultivation. We are now positioned as the most complete turnkey system in the industry.”

The company applied to uplist to the OTCQX Best Market in September, anticipating that it will be able to provide “additional transparency with our shareholders and wider communications with the investing community” while meeting more stringent market cap and revenue requirements (http://ibn.fm/iyKwC).

For more information, visit the company’s website at www.GrowPodSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to GWPD are available in the company’s newsroom at http://ibn.fm/GWPD

• OGI recently received government approval and licensing for 17 additional cultivation rooms
• The company’s licensed production capacity now totals 76,000 kilograms per year
• Organigram’s strategic plan for continued expansion is reportedly on schedule

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI), a leading Canadian licensed producer (LP) of premium-quality cannabis and extract-based products, has obtained Health Canada approval for licensing of 17 additional cultivation rooms. The move brings the company’s total target licensed production capacity to 76,000 kilograms per year (http://ibn.fm/hl2G8). This is the next step in the company’s strategic plan to increase capacity and further improve its efficiencies of scale.

The new cultivation rooms represent approximately 15,000 kilograms per year of additional production capacity and are part of Organigram’s strategic phase 4B expansion plan.

“Once again, we are pleased to receive licensing approval consistent with our expectations and the streamlined process we have experienced to date,” Organigram CEO Greg Engel stated in a news release. “Our phase 4 facility expansion remains on schedule to meet growing demand and further contribute to efficiencies of scale.”

As a result of the government licensing and approval, the company will immediately begin moving cannabis plants into the new rooms on a rolling basis. Organigram projects it will see the initial crop from these new rooms by the end of November 2019, assuming normal cultivation timelines. Following drying and post-harvest processing, the company anticipates having dried-flower product from these additional rooms available for sale to patients and customers in its fiscal quarter ending February 2020.

Additional construction outlined in phase 4B of the company’s expansion plans is on schedule to be completed later this month. The company plans on submitting the licensing amendment for its remaining 16 phase 4B cultivation rooms this month, as well. The perimeter of phase 5 of the company’s expansion, which will include an edibles and derivative product facility and more extraction capacity, is also planned for this Health Canada licensing submission (http://ibn.fm/beQXS).

Organigram Holdings Inc. is a Nasdaq Global Select and Toronto Stock Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing the highest-quality, condition-specific medical marijuana for patients in Canada, and it ships to all 10 Canadian provinces, establishing a growing coast-to-coast network. The company is certified by Ecocert Canada to produce organically grown medicinal cannabis. A portion of the cannabis currently produced in the facility is organically grown, and a portion is mineral grown.

The company is also committed to developing international business partnerships to extend its global footprint. In addition, Organigram has developed a portfolio of legal, adult-use recreational cannabis brands, including the Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick.

For more information, visit the company’s website at www.Investors.Organigram.ca

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://ibn.fm/OGRMF

• SPRWF released impressive numbers in its latest financial report
• The company highlighted its stable position in a roller-coaster industry
• The 7ACRES brand plays a key role in the company’s current and future growth initiatives

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) is ending its FY2019 as one of the few Canadian cannabis businesses building sustainable operations and valuable brands, according to the company’s FY2019 year-end report (http://ibn.fm/UworA). The report announced impressive numbers that indicate the company’s stable position in a sector that has been rocked by up-and-down performance throughout the year.

The company released its Q4 2019 and year-end financial results, noting the following:

• Total revenue for FY2019 was $41.8 million, a 370 percent increase from FY2018, which totaled $8.9 million;
• The company achieved its first positive adjusted EBITDA quarter of $3.2 million;
• Q4 2019 net revenue totaled $19 million, a 90 percent increase from Q3 2019, which reached $10 million; and
• Net revenue for fiscal 2020 is forecast to be between $150 million and $180 million, with positive adjusted EBITDA expected for fiscal 2020.

The company pointed to its core recreational flower brand, 7ACRES, as key to its impressive revenue performance. Committed to providing enthusiasts with hand-crafted cannabis flower that delivers an uncompromised experience, revenue from 7ACRES grew 443 percent year-over-year, from $3.5 million in Q4 2018 to $19 million in Q4 2019, and 90 percent quarter-over-quarter, from $10 million in Q3 2019.

“Our positive adjusted EBITDA and significant revenue growth in the fourth quarter reflects the rapid scale of our 7ACRES business and continued strong sales pricing for our brands from the provinces as we transition our premium supply to recreational sales channels,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release.

As 7ACRES focused on transitioning sales from its legacy wholesale contracts to recreational sales channels, the brand’s revenue from recreational markets increased by 51 percent between Q3 2019 and Q4 2019. In addition, 7ACRES continues to build equity among consumers, with the promise of new product forms and introduction of new proprietary strains like Jack Haze.

Jack Haze is the first sativa-dominant strain to enter the market under the 7ACRES brand and one of the few sativa-dominant strains available in Canada (http://ibn.fm/OSze3). With its novel traits and differentiated profile, Jack Haze is securing premium pricing in the provinces where it is available.

Supreme Cannabis CEO, Navdeep Dhaliwal concluded his remarks by commenting on some key growth drivers for the company.

“We began fiscal 2020 with two accretive acquisitions that expanded our addressable markets and provided valuable licensed operating assets and focused expertise,” Dhaliwal continued. “As we integrate these businesses and realize further efficiencies from our scaled 7ACRES operations, we expect all of our brands to meaningfully contribute to the revenue we have forecasted for fiscal 2020. Amidst the noise of this new marketplace, Supreme Cannabis has taken a strategic and disciplined approach to develop a focused business with clear pillars: best-in-class infrastructure, top consumer brands, advanced intellectual property, and high-impact and capital-light exposure to developing international markets.”

Supreme Cannabis’ portfolio includes 7ACRES, its wholly owned subsidiary and multi-award-winning brand; Blissco Cannabis Corp., a wellness cannabis brand and a multi-licensed processor and distributor based in British Columbia; Truverra Inc., a global medicinal cannabis brand and licensed cultivator; Cambium Plant Sciences, a plant genetics and cultivation IP company; Medigrow Lesotho, an cannabis oil producer located in southern Africa; Supreme Heights, an investment platform focused on CBD brands in the UK and Europe; and a brand partnership and licensing deal with Khalifa Kush Canada ULC.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF